Higher optical density of an antigen assay predicts thrombosis in patients with heparin-induced thrombocytopenia

European Journal of Haematology

Volumn 80, Issue 5, 2008, Pages 429-435

  Altuntas, Fevzi ^a   Matevosyan, Karen ^a   Burner, James ^a   Shen, Yu Min ^a   Sarode, Ravindra ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Enzyme linked immunosorbent assay; Heparin induced thrombocytopenia; Risk factors; Thrombosis

Indexed keywords

ARGATROBAN; AUTOANTIGEN; HEPARIN; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; THROMBIN INHIBITOR; THROMBOCYTE FACTOR 4;

ADULT; AGED; ARTICLE; DEMOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; MAJOR CLINICAL STUDY; MALE; OPTICAL DENSITY; PREDICTION; PRIORITY JOURNAL; PROPHYLAXIS; RETROSPECTIVE STUDY; RISK FACTOR; SEX RATIO; STATISTICAL ANALYSIS; THROMBOCYTE COUNT; THROMBOSIS;

AGED; ANTIGENS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPARIN; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; THROMBOCYTOPENIA; THROMBOSIS;

EID: 41849090415     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2008.01035.x     Document Type: Article

References (24)

1. Amiral J, Bridey F, Wolf M, et al. Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases. Thromb Haemost 1995 73 : 21 8.
2. Cines DB, Rauova L, Arepally G, et al. Heparin-induced thrombocytopenia: an autoimmune disorder regulated through dynamic autoantigen assembly/disassembly. J Clin Apher 2007 22 : 31 6.
3. Warkentin TE. Heparin-induced thrombocytopenia: pathogenesis and management. Br J Haematol 2003 121 : 535 55.
4. Zwicker JI, Uhl L, Huang WY, et al. Thrombosis and ELISA optical density values in hospitalized patients with heparin-induced thrombocytopenia. J Thromb Haemost 2004 2 : 2133 7.
5. Warkentin TE, Greinacher A. Laboratory testing for heparin-induced thrombocytopenia. In : Warkentin TE, Greinacher A, eds. Heparin-Induced Thrombocytopenia 3rd edn. New York, NY : Marcel Dekker, 2004 : 271 311.
6. Sheridan D, Carter C, Kelton JG. A diagnostic test for heparin-induced thrombocytopenia. Blood 1986 67 : 27 30.
7. Greinacher A, Amiral J, Dummel V, et al. Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelet aggregation test, heparin-induced platelet activation test, and platelet factor 4/heparin enzyme-linked immunosorbent assay. Transfusion 1994 34 : 381 5.
8. Arepally G, Reynolds C, Tomaski A, et al. Comparison of PF4/heparin ELISA assay with the 14C-serotonin release assay in the diagnosis of heparin-induced thrombocytopenia. Am J Clin Pathol 1995 104 : 648 54.
9. Warkentin TE, Sheppard JI. No significant improvement in diagnostic specificity of an anti-PF4/polyanion immunoassay with use of high heparin confirmatory procedure. J Thromb Haemost 2006 4 : 281 2.
10. Rice L, Attisha WK, Drexler A, et al. Delayed-onset heparin-induced thrombocytopenia. Ann Intern Med 2002 136 : 210 5.
11. Warkentin TE, Kelton JG. Delayed-onset heparin-induced thrombocytopenia and thrombosis. Ann Intern Med 2001 135 : 502 6.
12. Walenga JM, Jeske WP, Wood JJ, et al. Laboratory tests for heparin-induced thrombocytopenia: a multicenter study. Semin Hematol 1999 36 : 22 8.
13. Lindhoff-Last E, Gerdsen F, Ackermann H, et al. Determination of heparin-platelet factor 4-IgG antibodies improves diagnosis of heparin-induced thrombocytopenia. Br J Haematol 2001 113 : 886 90.
14. Risch L, Fischer JE, Schmugge M, et al. Association of anti-heparin platelet factor 4 antibody levels and thrombosis in pediatric intensive care patients without thrombocytopenia. Blood Coagul Fibrinolysis 2003 14 : 113 6.
15. Izban KF, Lietz HW, Hoppensteadt DA, et al. Comparison of two PF4/heparin ELISA assays for the laboratory diagnosis of heparin-induced thrombocytopenia. Semin Thromb Hemost 1999 25 (S1 51 6.
16. Suh JS, Malik MI, Aster RH, et al. Characterization of the humoral immune response in heparin-induced thrombocytopenia. Am J Hematol 1997 54 : 196 201.
17. Alberio L, Kimmerle S, Baumann A, et al. Rapid determination of anti-heparin/platelet factor 4 antibody titers in the diagnosis of heparin-induced thrombocytopenia. Am J Med 2003 114 : 528 36.
18. Untch B, Ahmad S, Jeske WP, et al. Prevalence, isotype, and functionality of antiheparin-platelet factor 4 antibodies in patients treated with heparin and clinically suspected for heparin-induced thrombocytopenia. The pathogenic role of IgG. Thromb Res 2002 105 : 117 23.
19. Girolami B, Prandoni P, Stefani PM, et al. The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study. Blood 2003 101 : 2955 9.
20. Warkentin TE, Levine MN, Hirsh J, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 1995 332 : 1330 5.
21. Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004 126 (3 Suppl 311S 37S.
22. Warkentin TE. New approaches to the diagnosis of heparin-induced thrombocytopenia. Chest 2005 127 (2 Suppl 35S 45S.
23. Warkentin TE, Sheppard JA, Sigouin CS, et al. Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia. Blood 2006 108 : 2937 41.
24. Bakaeen FG, Walkes JC, Reardon MJ. Heparin-induced thrombocytopenia associated with bilateral adrenal hemorrhage after coronary artery bypass surgery. Ann Thorac Surg 2005 79 : 1388 90.